查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421753

生物标记发现外包服务市场,份额,规模,趋势,行业分析报告:按类型,治疗领域,发现阶段,最终用途,地区,细分市场,预测2023-2032 年

Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area ; By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球生物标记发现外包服务的市场规模预计将达到 704.4 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

生物标记在临床试验中的使用不断增加，製药公司对生物标记研究服务外包的需求也增加。此外，製药业外包各个方面的业务（包括生物标记研究）的趋势日益明显，有助于市场扩张。同样受到推动的是液体活检的日益普及，这是一种分析血液、尿液和脑脊髓液等体液中生物标记的技术。液体活检的优点是比传统组织活检侵入性更小，并且可以即时提供资讯。随着液体活检的普及，对生物标记发现外包服务的需求也在增加，成为市场成长的关键因素。

由于药物开发和临床试验的增加，市场正在经历显着成长。生物标记在药物开发中已变得至关重要，可帮助製药公司确定适当的药物标靶、简化临床试验程序并确定适当的患者群体进行测试。Masu。截至2023年，全球临床试验状况如下：在ClinicalTrials.gov註册了452,604项临床试验，有64,838名活跃参与者。与 2021 年初约 365,000 项註册试验相比，这一数字显着增加，凸显了临床研究领域的强劲和持续扩张。

生物标誌物发现的未来在很大程度上依赖于组学技术的进步。基因组学、蛋白质组学、代谢组学和其他组学领域的重大进展使科学家能够识别新的生物标记。整合这些不同组学领域的数据对于生物标记识别非常有益。透过结合基因组学、蛋白质组学和代谢组学的见解，研究人员可以获得对复杂疾病的全面了解。

专门从事多组学资料整合的外包服务在此过程中发挥关键作用。这些专业服务提供者拥有驾驭不同组学数据的复杂性并有效整合它们的专业知识。透过将生物标记发现外包给这些专家，製药公司和研究机构可以利用最新的技术和方法来识别创新的生物标记物，这对于推进医疗保健领域的诊断和研究方法至关重要。

生物标誌物发现外包服务市场报告亮点

替代终点主导市场，因为它们提供了对药物作用机制的精确理解，为个人化治疗铺平了道路。

由于癌症患者数量的增加和癌症研究的投资，肿瘤学将占据最大的市场份额

北美由于其庞大的工业学术网络、研究资金和参与计算生物学的主要公司而占据了市场主导地位。

主要市场参与者包括Laboratory Corporation of America、Charles River Laboratories、Eurofins Scientific、Celerion、ICON、Parexel、Proteome Sciences等。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球生物标记发现外包服务市场洞察

  • 生物标记检测外包服务 - 产业概况
  • 生物标记发现外包服务市场动态
    • 驱动因素和机遇
      • 日益关注个人化医疗和标靶治疗
      • 高通量组学技术的进展
    • 限制因素和挑战
      • 对生物标记验证和临床实用性的了解有限
  • PESTLE分析
  • 生物标誌物发现外包服务的产业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章全球生物标记发现外包服务市场（依治疗领域）

  • 主要发现
  • 介绍
  • 肿瘤学
  • 神经病学
  • 心臟病学
  • 自身免疫性疾病
  • 其他

第六章全球生物标记发现外包服务市场（按类型）

  • 主要发现
  • 介绍
  • 预测性生物标记
  • 预后生物标记
  • 安全生物标记
  • 替代终点

第七章全球生物标记发现外包服务市场（依发现阶段）

  • 主要发现
  • 介绍
  • 生物标记鑑定
  • 生物标记验证
  • 生物标记分析
  • 生物标记组合开发
  • 生物标誌物选择

第八章全球生物标记发现外包服务市场（按最终用途）

  • 主要发现
  • 介绍
  • 製药公司
  • 生物技术公司
  • 其他

第九章全球生物标记发现外包服务市场（按地区）

  • 主要发现
  • 介绍
    • 生物标记发现外包服务市场评估，地区，2019-2032
  • 生物标誌发现外包服务市场—北美
    • 北美：2019-2032 年按治疗领域划分的生物标记发现外包服务市场
    • 北美：生物标记发现外包服务市场（按最终用途），2019-2032 年
    • 北美：2019-2032 年生物标记发现外包服务市场（按类型）
    • 北美：生物标记发现外包服务市场，按发现阶段划分，2019-2032 年
    • 生物标记发现外包服务市场—美国
    • 生物标誌发现外包服务市场—加拿大
  • 生物标记发现外包服务市场 - 欧洲
    • 欧洲：2019-2032 年生物标记发现外包服务市场（依治疗领域）
    • 欧洲：生物标记发现外包服务市场（按最终用途），2019-2032 年
    • 欧洲：2019-2032 年生物标记发现外包服务市场（按类型）
    • 欧洲：生物标记物发现外包服务市场，依发现阶段划分，2019-2032 年
    • 生物标记发现外包服务市场 - 英国
    • 生物标誌发现外包服务市场—法国
    • 生物标誌发现外包服务市场—德国
    • 生物标誌发现外包服务市场—义大利
    • 生物标誌发现外包服务市场—西班牙
    • 生物标记发现外包服务市场—荷兰
    • 生物标誌发现外包服务市场—俄罗斯
  • 生物标记发现外包服务市场 - 亚太地区
    • 亚太地区：2019-2032 年生物标记发现外包服务市场（依治疗领域）
    • 亚太地区：2019-2032 年生物标记物发现外包服务市场（依最终用途）
    • 亚太地区：2019-2032 年生物标记发现外包服务市场（按类型）
    • 亚太地区：生物标记物发现外包服务市场，依发现阶段划分，2019-2032 年
    • 生物标誌发现外包服务市场 - 中国
    • 生物标誌发现外包服务市场—印度
    • 生物标誌发现外包服务市场—日本
    • 生物标誌发现外包服务市场 - 马来西亚
    • 生物标誌发现外包服务市场—印度尼西亚
    • 生物标誌发现外包服务市场—韩国
  • 生物标记发现外包服务市场—中东和非洲
    • 中东和非洲：2019-2032 年按治疗领域划分的生物标记发现外包服务市场
    • 中东和非洲：2019-2032 年生物标记物发现外包服务市场（以最终用途）
    • 中东和非洲：2019-2032 年生物标记发现外包服务市场（按类型）
    • 中东和非洲：生物标记物发现外包服务市场，按发现阶段划分，2019-2032 年
    • 生物标誌物发现外包服务市场 - 沙乌地阿拉伯
    • 生物标记发现外包服务市场—南非
    • 生物标记发现外包服务市场 - 以色列
    • 生物标誌发现外包服务市场—阿拉伯联合大公国
  • 生物标记发现外包服务市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年按治疗领域划分的生物标记发现外包服务市场
    • 拉丁美洲：生物标记发现外包服务市场（按最终用途），2019-2032 年
    • 拉丁美洲：2019-2032 年生物标记发现外包服务市场（按类型）
    • 拉丁美洲：生物标记物发现外包服务市场，按发现阶段划分，2019-2032 年
    • 生物标誌发现外包服务市场—墨西哥
    • 生物标誌发现外包服务市场—巴西
    • 生物标誌发现外包服务市场—阿根廷

第10章竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第十一章公司简介

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories
  • Eurofins Scientific
  • Celerion
  • ICON plc
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec
Product Code: PM4075

The global biomarker discovery outsourcing services market size is expected to reach USD 70.44 billion by 2032, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others); By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising use of biomarkers in clinical trials, leading to an increased demand for outsourced biomarker research services by pharmaceutical companies. Additionally, the pharmaceutical industry is increasingly outsourcing various aspects of its operations, including biomarker research, contributing to the market's expansion. Another driving force is the growing adoption of liquid biopsies, a technique that involves analyzing biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid. Liquid biopsies offer advantages over traditional tissue biopsies, being less invasive and providing real-time information. As the popularity of liquid biopsies rises, the demand for biomarker discovery outsourcing services is also increasing, making it a pivotal factor in the market's growth.

The market is experiencing significant growth due to the rise in drug development and clinical trials. Biomarkers have become pivotal in drug development, aiding pharmaceutical companies in pinpointing appropriate drug targets, streamlining clinical trial procedures, and identifying suitable patient populations for trials. As of 2023, the global clinical trial landscape boasts an impressive 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This marks a substantial increase compared to the approximately 365,000 registered trials noted in early 2021, highlighting the robust and continuous expansion within the realm of clinical research.

The future of biomarker discovery is heavily reliant on advancements in omics technologies. Genomics, proteomics, metabolomics, and other omics disciplines have made significant progress, allowing scientists to identify new biomarkers. Integrating data from these various omics fields is incredibly beneficial for biomarker identification. By combining insights from genomics, proteomics, and metabolomics, researchers can gain a comprehensive understanding of complex disorders.

Outsourcing services that specialize in multi-omics data integration play a crucial role in this process. These specialized service providers have the expertise to navigate the complexities of different omics data and integrate them effectively. By outsourcing biomarker discovery efforts to these experts, pharmaceutical companies and research institutions can leverage the latest technologies and methodologies, leading to the identification of innovative biomarkers essential for advancing diagnostics and therapeutics in the field of healthcare.

Biomarker Discovery and Outsourcing Services Market Report Highlights

Surrogate endpoints dominated the market, as they precise drug's mechanism of action, paving the way for personalized therapies.

The oncology segment held the largest share, owing to rising cases of cancer and investments in cancer research

North America dominated the market, as it possesses a huge industry-academia network, the presence of research funding, and key companies involved in computational biology

The key market players include Laboratory Corporation of America, Charles River Laboratories, Eurofins Scientific, Celerion, ICON, Parexel, and Proteome Sciences

Polaris Market Research has segmented the biomarker discovery and outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

Biomarker Discovery and Outsourcing Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Predictive biomarkers
  • Prognostic biomarkers
  • Safety biomarkers
  • Surrogate endpoints

Biomarker Discovery and Outsourcing Services, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Neurology
  • Cardiology
  • Autoimmune Diseases
  • Others

Biomarker Discovery and Outsourcing Services, Discovery Phase Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Profiling
  • Biomarker Panel Development
  • Biomarker Selection

Biomarker Discovery and Outsourcing Services, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others

Biomarker Discovery and Outsourcing Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

  • 4.1. Biomarker Discovery Outsourcing Services - Industry Snapshot
  • 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing focus on personalized medicine and targeted therapies
      • 4.2.1.2. Advancements in high-throughput omics technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. limited understanding of biomarker validation and clinical utility
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Biomarker Discovery Outsourcing Services Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.4. Neurology
    • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2019-2032 (USD Billion)
  • 5.5. Cardiology
    • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2019-2032 (USD Billion)
  • 5.6. Autoimmune Diseases
    • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Predictive biomarkers
    • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.4. Prognostic biomarkers
    • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.5. Safety biomarkers
    • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.6. Surrogate endpoints
    • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2019-2032 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 7.3. Biomarker Identification
    • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2019-2032 (USD Billion)
  • 7.4. Biomarker Validation
    • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2019-2032 (USD Billion)
  • 7.5. Biomarker Profiling
    • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2019-2032 (USD Billion)
  • 7.6. Biomarker Panel Development
    • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2019-2032 (USD Billion)
  • 7.7. Biomarker Selection
    • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2019-2032 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 8.3. Pharmaceutical Companies
    • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 8.4. Biotechnology Companies
    • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2019-2032 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Biomarker Discovery Outsourcing Services Market - North America
    • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.3.5. Biomarker Discovery Outsourcing Services Market - U.S.
      • 9.3.5.1. U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
      • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4. Biomarker Discovery Outsourcing Services Market - Europe
    • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
      • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
      • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
      • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
      • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
      • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
      • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
      • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
    • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
      • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
      • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.7. Biomarker Discovery Outsourcing Services Market - Japan
      • 9.5.7.1. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.8. Biomarker Discovery Outsourcing Services Market - Malaysia
      • 9.5.8.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
      • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
      • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.6. Biomarker Discovery Outsourcing Services Market - South Africa
      • 9.6.6.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
      • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.8. Biomarker Discovery Outsourcing Services Market - UAE
      • 9.6.8.1. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
    • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
      • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
      • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
      • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Laboratory Corporation of America Holdings
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Eurofins Scientific
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Celerion
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. ICON plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Parexel International (MA) Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Proteome Sciences
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. GHO Capital
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Thermo Fisher Scientific Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Evotec
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables

  • Table 1 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Biomarker Discovery Outsourcing Services Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 8 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 9 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 13 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 17 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 21 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 23 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 25 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 27 France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 28 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 29 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 30 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 31 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 32 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 33 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 37 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 43 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 45 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 49 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 54 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 55 China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 56 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 57 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 59 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 61 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 63 India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 64 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 65 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 75 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 79 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 81 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 83 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 85 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 87 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 89 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 91 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 93 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 101 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 109 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 111 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 113 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Area
  • Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Discovery Phase
  • Figure 13. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2021 & 2030 (USD Billion)